Back to Screener

Shoulder Innovations, Inc. (SI)

Price$14.28
Growth ScoreB
Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-15.44%
Price vs S&P 500 (4W)8.19%
VGM Score63.69
Market Capitalization$296.14M

All Metrics

Book Value / Share (Quarterly)$6.42
P/TBV (Annual)2.09x
Revenue Growth (3Y)59.26%
Cash Flow / Share (Quarterly)$-2.12
Price vs S&P 500 (YTD)-8.30%
Gross Margin (TTM)76.98%
Net Profit Margin (TTM)-17.14%
EPS (TTM)$-1.01
10-Day Avg Trading Volume0.07M
EPS Excl Extra (TTM)$-1.01
Revenue Growth (5Y)46.62%
EPS (Annual)$-1.41
ROI (Annual)-7.86%
Gross Margin (Annual)76.51%
Cash / Share (Quarterly)$5.24
Revenue Growth QoQ (YoY)64.90%
ROA (Last FY)-7.20%
Revenue Growth TTM (YoY)151.02%
EBITD / Share (TTM)$-1.45
Operating Margin (TTM)-55.39%
Cash Flow / Share (Annual)$-1.75
P/B Ratio2.23x
P/B Ratio (Quarterly)2.26x
Net Income / Employee (Annual)$-169,900
ROA (TTM)-10.89%
EPS Incl Extra (Annual)$-1.41
Current Ratio (Annual)11.07x
Quick Ratio (Quarterly)9.91x
3-Month Avg Trading Volume0.09M
52-Week Price Return-98.93%
Revenue / Employee (TTM)$585,200
Tangible BV / Share (Quarterly)$6.42
P/S Ratio (Annual)6.26x
Asset Turnover (Annual)0.28x
52-Week High$17.94
EPS Excl Extra (Annual)$-1.41
Tangible BV CAGR (5Y)52.22%
26-Week Price Return-7.51%
Quick Ratio (Annual)9.44x
13-Week Price Return9.59%
Total Debt / Equity (Annual)0.11x
Current Ratio (Quarterly)11.81x
Enterprise Value$299.61M
Asset Turnover (TTM)0.31x
Book Value / Share Growth (5Y)36.95%
Revenue / Employee (Annual)$657,200
Pretax Margin (Annual)-25.86%
Cash / Share (Annual)$6.03
3-Month Return Std Dev56.07%
Net Income / Employee (TTM)$-221,600
EBITDA Interim CAGR (5Y)53.41%
ROE (Last FY)-8.69%
EPS Basic Excl Extra (Annual)$-1.41
Receivables Turnover (TTM)4.92x
Total Debt / Equity (Quarterly)0.11x
EPS Incl Extra (TTM)$-1.01
ROI (TTM)-12.00%
P/S Ratio (TTM)7.03x
Revenue / Share (Annual)$5.46
Tangible BV / Share (Annual)$6.82
Free OCF CAGR (5Y)187.99%
EPS Growth TTM (YoY)-1135.45%
Year-to-Date Return-0.14%
5-Day Price Return0.71%
EPS Normalized (Annual)$-1.41
Net Profit Margin (Annual)-25.86%
Month-to-Date Return-2.86%
Cash Flow / Share (TTM)$3.28
EBITD / Share (Annual)$-2.66
Operating Margin (Annual)-55.58%
LT Debt / Equity (Annual)0.11x
LT Debt / Equity (Quarterly)0.11x
EPS Basic Excl Extra (TTM)$-1.01
P/TBV (Quarterly)2.26x
P/B Ratio (Annual)2.09x
Inventory Turnover (TTM)0.72x
Pretax Margin (TTM)-17.14%
Book Value / Share (Annual)$6.82
Price vs S&P 500 (13W)1.34%
Beta14.51x
P/FCF (Annual)2.24x
Revenue / Share (TTM)$2.04
ROE (TTM)-13.57%
52-Week Low$10.92
gGradeB
mGradeC
vgmGradeB
Show chart for

Earnings Surprise History

Q1 26-0.41est. -0.42

Analyst Recommendations

Feb 2026
Mar 2026
Apr 2026
May 2026
4.31
4.31
4.33
4.33

Industry Peers — Surgical & Medical Instruments(138)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
SIShoulder Innovations, Inc.
BC$14.28
SYKStryker CorporationCCC$305.66
MMM3M CompanyCFC$153.76
BSXBoston Scientific Corp.CBD$48.55
MDLNMedline Inc. Class A common stockCDD$33.61
BDXBecton, Dickinson and Co.BCC$151.16
RMDResMed Inc.CBC$196.04
DXCMDexCom, Inc.CBC$72.86
WSTWest Pharmaceutical Services, Inc.DCB$314.50
SOLVSolventum CorporationCDB$81.01
PENPenumbra, Inc.FCB$320.53

About

Shoulder Innovations is a commercial-stage medical device company specializing in shoulder arthroplasty solutions. Its product portfolio includes InSet Total and Reverse Shoulder Arthroplasty systems, along with ProVoyance surgical planning software and the InSet Tray System. The company targets the shoulder replacement market within orthopedic surgery.